Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26863781 | 0.81 | OPRM1 (0.50) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL22224030 | 0.80 | — | — | |
| Water SCHEMBL10400451 | 0.79 | OPRM1 (0.48) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL17882175 | 0.78 | LMNA (0.43) | ACACBACACA | |
| SCHEMBL10706765 | 0.78 | OPRM1 (0.52) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL10922365 | 0.77 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL26101017 | 0.77 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL49007 | 0.77 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL28211132 | 0.77 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 | |
| SCHEMBL7734724 | 0.77 | OPRM1 (0.71) | OPRM1TP53TRPV1TRPA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5405997-A | Stable against rapid metabolism | THE UPJOHN COMPANY (US) | 1995-04-11 | — | — | US | disclosed |